Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. May 15, 2024; 16(5): 1925-1946
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1925
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1925
Figure 8 METTL5 blunted the sensitivity of gastric cancer cells to cisplatin.
A: Clone formation assay to detect the effect of cisplatin on the clone formation ability of gastric cancer cells after METTL5 knockdown; B: Transwell assay to detect the effect of cisplatin on the migration ability of gastric cancer cells after METTL5 knockdown. aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Zhang YQ, Li J, Qin Z, Li DM, Ye FZ, Bei SH, Zhang XH, Feng L. METTL5 promotes gastric cancer progression via sphingomyelin metabolism. World J Gastrointest Oncol 2024; 16(5): 1925-1946
- URL: https://www.wjgnet.com/1948-5204/full/v16/i5/1925.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i5.1925